https://www.switzerlandtechreview.com/article/908746177-atlantic-international-expands-1-2b-unaudited-platform-into-ai-cybersecurity-data-infrastructure-through-circle8 Switzerland Tech Review en PressRelease 2026-04-28T15:13:03+00:00 Atlantic International Expands $1.2B (Unaudited) Platform into AI, Cybersecurity & Data Infrastructure Through Circle8 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842683-guus-franke-1200x628.jpeg https://www.switzerlandtechreview.com/article/908682981-procuretech-leaders-summit-2026-not-just-a-summit-a-place-where-procurement-connections-come-alive Switzerland Tech Review en PressRelease 2026-04-28T08:48:49+00:00 ProcureTech Leaders Summit 2026 : Not Just a Summit - A Place Where Procurement Connections Come Alive https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842458-sponsors-procuretech-leaders-su-1600x896.png https://www.switzerlandtechreview.com/article/905622872-swiss-biome-sets-a-new-standard-in-skin-brain-health-with-trailblazing-microbiome-derived-metabolite-complex Switzerland Tech Review en PressRelease 2026-04-28T06:30:00+00:00 Swiss Biome Sets a New Standard in Skin-Brain Health with Trailblazing Microbiome-Derived Metabolite Complex https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841476-swiss-biome-celine-2400x1600.png https://www.switzerlandtechreview.com/article/908661449-stmicroelectronics-brings-always-on-vision-to-next-generation-personal-electronics-with-new-ultralow-power-image-sensors Switzerland Tech Review en PressRelease 2026-04-28T06:00:00+00:00 STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors https://ml-eu.globenewswire.com/media/9c3abad0-fa8a-4618-b6ed-4d0592ac6835/medium/st-s-new-brightsense-image-sensors.jpg https://www.switzerlandtechreview.com/article/908647942-santhera-gibt-positive-entscheidung-des-aifa-vorstands-zur-erstattung-von-agamree-vamorolon-in-italien-bekannt Switzerland Tech Review en PressRelease 2026-04-28T05:01:00+00:00 Santhera gibt positive Entscheidung des AIFA-Vorstands zur Erstattung von AGAMREE® (Vamorolon) in Italien bekannt https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.switzerlandtechreview.com/article/908647946-santhera-announces-positive-aifa-board-decision-on-reimbursement-of-agamree-vamorolone-in-italy Switzerland Tech Review en PressRelease 2026-04-28T05:01:00+00:00 Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.switzerlandtechreview.com/article/908647980-santhera-pharmaceuticals-jahresergebnisse-f-r-das-am-31-dezember-2025-endende-gesch-ftsjahr Switzerland Tech Review en PressRelease 2026-04-28T05:00:00+00:00 Santhera Pharmaceuticals Jahresergebnisse für das am 31. Dezember 2025 endende Geschäftsjahr https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.switzerlandtechreview.com/article/908647989-santhera-pharmaceuticals-full-year-results-for-the-year-ended-31-december-2025 Switzerland Tech Review en PressRelease 2026-04-28T05:00:00+00:00 Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025 https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.switzerlandtechreview.com/article/908365075-swiss-quantum-safe-l1-qorechain-launches-guardians-program-with-on-chain-credentials-and-capped-ranks Switzerland Tech Review en PressRelease 2026-04-27T12:00:00+00:00 Swiss Quantum-Safe L1 QoreChain Launches Guardians Program with On-Chain Credentials and Capped Ranks https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24841257-qorechain-guardians-cohort-1-a-1200x630.png https://www.switzerlandtechreview.com/article/908378484-santhera-erh-lt-positive-stellungnahme-des-chmp-zur-ausweitung-der-anwendung-von-agamree-vamorolon-bei-p-diatrischen-dmd-patienten-ab-zwei-jahren Switzerland Tech Review en PressRelease 2026-04-27T05:00:00+00:00 Santhera erhält positive Stellungnahme des CHMP zur Ausweitung der Anwendung von AGAMREE® (Vamorolon) bei pädiatrischen DMD-Patienten ab zwei Jahren in der EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.switzerlandtechreview.com/article/908378495-santhera-receives-positive-chmp-opinion-to-expand-agamree-vamorolone-use-in-pediatric-dmd-patients-aged-two-and-older-in-the-eu Switzerland Tech Review en PressRelease 2026-04-27T05:00:00+00:00 Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG